Don’t play with numbers

This editorial looks at how to present statistical information in a way that is easy for readers to interpret and apply, and calls on everyone involved writing educational material and press releases to make a [more]

Time to act on trials

Number 52

1 January 2013 0

Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]

Personalised medicine: a note of caution

1 September 2012 0

Tailoring a patient’s treatment to the particular biology of their cancer holds out the enticing prospect of avoiding over-treatment and reducing unnecessary toxicity. But delivering the right option for the right patient at the right [more]

1 2 3 4 5 7
UA-77507851-1